Medical Web Sites for patient education

 

Diabetes  Cholesterol & heart attacks        

Weight reduction      Fever management

Jaundice-Hepatitis A   High blood pressure

Depression & sleep disorders  Asthma 

Arthritis modern management

Dr. Shashank Jain

 

Hypothyroidism disease & management

Jains Clinic, E-2 Church compound, Sukhdev Vihar, New Delhi-25; India

Tel: Clinic: 011-26922890   Mobile : 9312403074, 9868856511 

E-mail: [email protected]

Home ] Hypothyroidism classification ] Risk factors ] Clinical features ] End organ impact ] Associated illnesses ] Diagnosis ] Treatment ] Dose titration ] Drug interactions ] Monitoring & follow up ] [ Myxedema coma ]

Myxedema coma

 

Myxedema coma occurs as an extreme manifestation of severe hypothyroidism, seen in patients with long standing hypothyroidism that is untreated.

 

Precipitating events

  1. Cold months

  2. Pulmonary events

  3. Cerebrovascular accidents

  4. Congestive heart failure

  5. Metabolic derangements

  6. Drugs- sedatives, narcotics, antidepressants

 

Cardinal Features

  1. Hypothermia

  2. Unconsciousness

  3. Other signs of hypothyroidism

 

Treatment 

Treatment of underlying cause 

Ventillatory support 

Correction of electrolyte imbalance, hypothermia, hypotension.

Steroid treatment -Inj Hydrocortisone 100mg, 8 hourly parennterally during initial 7 -10 days then tapered off .

Once patient is stable, consider evaluation of adrenal status.

 

Thyroid Hormone Therapy (Thyroxine Sodium) 

Initial dose (loading dose ), 100-500mcg followed by maintenance dose of 50-100mcg/day.

Parenteral preparations if not available, thyroxine tablets to be used through nasogastric tube, 500- 1000 mcg initial dose followed by 50-100 mcg /day. 

Care to be taken if patient has ischemic heart disease.

Due to illness, T4 given may not be converted to T3 so some advise T3 therapy

 

T3 treatment: Quick onset of action

Bolus IV (Triiodothyronine) T3 20mcg, followed by 10 mcg of T3 for first 24 hours and 10 mcg 6 hourly for next 2-3 days, then oral administration is started once patient is stable. 

However intravenous T3 therapy is marked by large and unpredictable fluctuations in serum T3 levels and is dangerous to the cardiac status.

 

Some advocate combination of T3 and T4 treatment

 

For further information, contact Dr. Shashank Jain

Jains Clinic, E-2 Church compound, Sukhdev Vihar, New Delhi-25; India

Tel: Clinic: 011-26922890   Mobile : 9312403074, 9868856511 

E-mail: [email protected]

Hosted by www.Geocities.ws

1